TY - JOUR AU - Russell, S. J. PY - 2002 DA - 2002// TI - RNA viruses as virotherapy agents JO - Cancer Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.cgt.7700535 DO - 10.1038/sj.cgt.7700535 ID - Russell2002 ER - TY - JOUR AU - McCormick, F. PY - 2003 DA - 2003// TI - Cancer-specific viruses and the development of ONYX-015 JO - Cancer Biol Ther VL - 2 UR - https://doi.org/10.4161/cbt.216 DO - 10.4161/cbt.216 ID - McCormick2003 ER - TY - JOUR AU - Heise, C. AU - Sampson-Johannes, A. AU - Williams, A. AU - McCormick, F. AU - Von Hoff, D. D. AU - Kirn, D. H. PY - 1997 DA - 1997// TI - ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents JO - Nat Med VL - 3 UR - https://doi.org/10.1038/nm0697-639 DO - 10.1038/nm0697-639 ID - Heise1997 ER - TY - JOUR AU - Kurihara, T. AU - Brough, D. E. AU - Kovesdi, I. AU - Kufe, D. W. PY - 2000 DA - 2000// TI - Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen JO - J Clin Invest VL - 106 UR - https://doi.org/10.1172/JCI9180 DO - 10.1172/JCI9180 ID - Kurihara2000 ER - TY - JOUR AU - Wirth, T. AU - Zender, L. AU - Schulte, B. AU - Mundt, B. AU - Plentz, R. AU - Rudolph, K. L. AU - Manns, M. AU - Kubicka, S. AU - Kuhnel, F. PY - 2003 DA - 2003// TI - A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer JO - Cancer Res VL - 63 ID - Wirth2003 ER - TY - JOUR AU - Nemunaitis, J. AU - Cunningham, C. AU - Tong, A. W. AU - Post, L. AU - Netto, G. AU - Paulson, A. S. AU - Rich, D. AU - Blackburn, A. AU - Sands, B. AU - Gibson, B. PY - 2003 DA - 2003// TI - Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients JO - Cancer Gene Ther VL - 10 UR - https://doi.org/10.1038/sj.cgt.7700585 DO - 10.1038/sj.cgt.7700585 ID - Nemunaitis2003 ER - TY - JOUR AU - Hann, B. AU - Balmain, A. PY - 2003 DA - 2003// TI - Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants JO - J Virol VL - 77 UR - https://doi.org/10.1128/JVI.77.21.11588-11595.2003 DO - 10.1128/JVI.77.21.11588-11595.2003 ID - Hann2003 ER - TY - JOUR AU - Kurooka, M. AU - Kaneda, Y. PY - 2007 DA - 2007// TI - Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-1615 DO - 10.1158/0008-5472.CAN-06-1615 ID - Kurooka2007 ER - TY - JOUR AU - Kaneda, Y. AU - Nakajima, T. AU - Nishikawa, T. AU - Yamamoto, S. AU - Ikegami, H. AU - Suzuki, N. AU - Nakamura, H. AU - Morishita, R. AU - Kotani, H. PY - 2002 DA - 2002// TI - Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system JO - Mol Ther VL - 6 UR - https://doi.org/10.1006/mthe.2002.0647 DO - 10.1006/mthe.2002.0647 ID - Kaneda2002 ER - TY - JOUR AU - Mima, H. AU - Yamamoto, S. AU - Ito, M. AU - Tomoshige, R. AU - Tabata, Y. AU - Tamai, K. AU - Kaneda, Y. PY - 2006 DA - 2006// TI - Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-05-0352 DO - 10.1158/1535-7163.MCT-05-0352 ID - Mima2006 ER - TY - JOUR AU - Steinman, R. M. AU - Mellman, I. PY - 2004 DA - 2004// TI - Immunotherapy: bewitched, bothered, and bewildered no more JO - Science VL - 305 UR - https://doi.org/10.1126/science.1099688 DO - 10.1126/science.1099688 ID - Steinman2004 ER - TY - JOUR AU - Blattman, J. N. AU - Greenberg, P. D. PY - 2004 DA - 2004// TI - Cancer immunotherapy: a treatment for the masses JO - Science VL - 305 UR - https://doi.org/10.1126/science.1100369 DO - 10.1126/science.1100369 ID - Blattman2004 ER - TY - JOUR AU - Pawelec, G. PY - 2004 DA - 2004// TI - Immunotherapy and immunoselection – tumour escape as the final hurdle JO - FEBS Lett VL - 567 UR - https://doi.org/10.1016/j.febslet.2004.02.091 DO - 10.1016/j.febslet.2004.02.091 ID - Pawelec2004 ER - TY - JOUR AU - Ahmad, M. AU - Rees, R. C. AU - Ali, S. A. PY - 2004 DA - 2004// TI - Escape from immunotherapy: possible mechanisms that influence tumor regression/progression JO - Cancer Immunol Immunother VL - 53 UR - https://doi.org/10.1007/s00262-004-0540-x DO - 10.1007/s00262-004-0540-x ID - Ahmad2004 ER - TY - JOUR AU - Staveley-O'Carroll, K. AU - Sotomayor, E. AU - Montgomery, J. AU - Borrello, I. AU - Hwang, L. AU - Fein, S. AU - Pardoll, D. AU - Levitsky, H. PY - 1998 DA - 1998// TI - Induction of antigen-specific T cell anergy: An early event in the course of tumor progression JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.3.1178 DO - 10.1073/pnas.95.3.1178 ID - Staveley-O'Carroll1998 ER - TY - JOUR AU - Wick, M. AU - Dubey, P. AU - Koeppen, H. AU - Siegel, C. T. AU - Fields, P. E. AU - Chen, L. AU - Bluestone, J. A. AU - Schreiber, H. PY - 1997 DA - 1997// TI - Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy JO - J Exp Med VL - 186 UR - https://doi.org/10.1084/jem.186.2.229 DO - 10.1084/jem.186.2.229 ID - Wick1997 ER - TY - JOUR AU - Steinbrink, K. AU - Graulich, E. AU - Kubsch, S. AU - Knop, J. AU - Enk, A. H. PY - 2002 DA - 2002// TI - CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity JO - Blood VL - 99 UR - https://doi.org/10.1182/blood.V99.7.2468 DO - 10.1182/blood.V99.7.2468 ID - Steinbrink2002 ER - TY - JOUR AU - Banat, G. A. AU - Christ, O. AU - Cochlovius, B. AU - Pralle, H. B. AU - Zoller, M. PY - 2001 DA - 2001// TI - Tumour-induced suppression of immune response and its correction JO - Cancer Immunol Immunother VL - 49 UR - https://doi.org/10.1007/s002620000153 DO - 10.1007/s002620000153 ID - Banat2001 ER - TY - JOUR AU - Gardini, A. AU - Ercolani, G. AU - Riccobon, A. AU - Ravaioli, M. AU - Ridolfi, L. AU - Flamini, E. AU - Ridolfi, R. AU - Grazi, G. L. AU - Cavallari, A. AU - Amadori, D. PY - 2004 DA - 2004// TI - Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis JO - J Surg Oncol VL - 87 UR - https://doi.org/10.1002/jso.20066 DO - 10.1002/jso.20066 ID - Gardini2004 ER - TY - JOUR AU - Smith, R. E. AU - Colangelo, L. AU - Wieand, H. S. AU - Begovic, M. AU - Wolmark, N. PY - 2004 DA - 2004// TI - Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01 JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh220 DO - 10.1093/jnci/djh220 ID - Smith2004 ER - TY - JOUR AU - McMillan, T. J. AU - Hart, I. R. PY - 1987 DA - 1987// TI - Can cancer chemotherapy enhance the malignant behaviour of tumours? JO - Cancer Metastasis Rev VL - 6 UR - https://doi.org/10.1007/BF00047465 DO - 10.1007/BF00047465 ID - McMillan1987 ER - TY - JOUR AU - Allen, T. M. AU - Cullis, P. R. PY - 2004 DA - 2004// TI - Drug delivery systems: entering the mainstream JO - Science VL - 303 UR - https://doi.org/10.1126/science.1095833 DO - 10.1126/science.1095833 ID - Allen2004 ER - TY - JOUR AU - Minko, T. AU - Dharap, S. S. AU - Pakunlu, R. I. AU - Wang, Y. PY - 2004 DA - 2004// TI - Molecular targeting of drug delivery systems to cancer JO - Curr Drug Targets VL - 5 UR - https://doi.org/10.2174/1389450043345443 DO - 10.2174/1389450043345443 ID - Minko2004 ER - TY - STD TI - Fujihara A, Kurooka M, Miki T, Kaneda Y: Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Cancer Immunology Immunotherapy. ID - ref24 ER - TY - STD TI - Kawano H, Komaba S, Yamasaki T, Maeda M, Kimura Y, Maeda A, Kaneda Y: New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin. Cancer Chemother Pharmacol. ID - ref25 ER - TY - JOUR AU - Ito, M. AU - Yamamoto, S. AU - Nimura, K. AU - Hiraoka, K. AU - Tamai, K. AU - Kaneda, Y. PY - 2005 DA - 2005// TI - Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin JO - J Gene Med VL - 7 UR - https://doi.org/10.1002/jgm.753 DO - 10.1002/jgm.753 ID - Ito2005 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/5/28/prepub UR - http://www.biomedcentral.com/1741-7015/5/28/prepub ID - ref27 ER -